Business Daily Media

Men's Weekly

.

Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19

  • Written by ACN Newswire - Press Releases
ADELAIDE, AU, Mar 12, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19.

Atossa Therapeutics, Inc.

Read more //?#

Brisbane’s brightest recognised: Daniel Mikus and James Rolph win Specialist Services Award at the 2025 Brisbane Young Entrepreneur Awards - again

Young Brisbane entrepreneurs Daniel Mikus and James Rolph, cofounders of MR Group, have been officially crowned winners of the Specialist Services...

Members greenlight merger of Regional Australia Bank and Summerland Bank

Regional Australia Bank and Summerland Bank will proceed with a merger after members approved the move at their Annual General Meetings this week...

DesignStreet marks 27 years with a bold rebrand

In a fast-moving industry defined by continuous disruption, one independent creative agency is proving that longevity and innovation can go hand i...

Deputy partners with SuperAPI to streamline employee onboarding and help get shift-based industries ready for PayDay Super

Deputy, the global people platform for shift-based work, has announced a new partnership with SuperAPI, marking a major enhancement to its HR pro...

KuCoin invests in Australian sponsorships of the ACC, plus a major campaign with golf icon Adam Scott

KuCoin, a leading global crypto platform built on trust, announced the appointment of James Pinch as the Australian Managing Director, the establish...

Australian companies pitching to the world’s wealthiest investors

#CapTech 2025 to bring world investors to Australia’s doorstep  One of Australia’s leading business and capital events is bringing together inves...